Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non-acral nevus-associated melanoma in situ: An institutional experience and meta-analysis.
Chau M BuiHuy Gia VuongMinh-Khang LeJosephine D'AngeloKathleen MannavaBruce R SmollerPublished in: Journal of cutaneous pathology (2024)
PRAME is a valuable immunohistochemical marker for differentiating MIS from DN, particularly in the context of nevus-associated MIS.